Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Terlipressin Adjusted to Hemodynamic Response in Hepatorenal Syndrome
NCT01530711Phase 4Unknown
- Start
- Apr 2012
- Primary completion
- Dec 2016
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of terlipressin in hepatorenal syndrome type 1 (HRS-1). Status: unknown.
02
Drugs
terlipressin
03
Conditions
hepatorenal syndrome type 1 (HRS-1)
Beyond the preview
Go deeper on NCT01530711.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01530711.